Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer

Which subgroups patients with muscle-invasive bladder cancer (MIBC) could benefit most from adjuvant chemotherapy (ACT) is blurred. Here we tried to stratify MIBC patients with tumor infiltrating mast cells (TIMs), explore the prognostic and predictive value of TIMs, and provide possible cellular ex...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Liu, Zheng, Zhu, Yu, Xu, Le, Zhang, Junyu, Xie, Huyang, Fu, Hangcheng, Zhou, Quan, Chang, Yuan, Dai, Bo, Xu, Jiejie
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209422/
https://ncbi.nlm.nih.gov/pubmed/30393586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1474317
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados